National Institutes of Health
Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)
Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed) is a funding opportunity from National Institutes of Health, closing October 28, 2027.
Overview
Opportunity Listing - Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)Skip to main contentSign in to Simpler.Grants.govSimpler.Grants.gov uses Login.gov to verify your identity and manage your account securely.…